E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/14/2017 in the Prospect News Structured Products Daily.

New Issue: JPMorgan prices $1.45 million contingent buffer return enhanced notes tied to stocks

By Susanna Moon

Chicago, Sept. 14 – JPMorgan Chase Financial Co. LLC priced $1.45 million of 0% contingent buffered return enhanced notes due Sept. 11, 2020 tied to a basket of equally weighted common stocks, according to a 424B2 filing with the Securities and Exchange Commission.

The underlying companies are Pfizer Inc., Bristol-Myers Squibb Co., Merck & Co., Inc. and Eli Lilly and Co.

If the basket finishes at or above the initial level, the payout at maturity will be par plus 1.4 times any basket gain, up to a maximum return of 35%.

Investors will receive par if the basket falls by up to the 30% contingent buffer.

Otherwise, investors will be exposed to any losses.

The notes are guaranteed by JPMorgan Chase & Co.

J.P. Morgan Securities LLC is the agent.

Issuer:JPMorgan Chase Financial Co. LLC
Guarantor:JPMorgan Chase & Co.
Issue:Contingent buffered return enhanced notes
Underlying basket:Pfizer Inc. (NYSE: PFE), Bristol-Myers Squibb Co. (NYSE: BMY), Merck & Co., Inc. (NYSE: MRK) and Eli Lilly and Co. (NYSE: LLY)
Amount:$1.45 million
Maturity:Sept. 11, 2020
Coupon:0%
Price:Par
Payout at maturity:Par plus 1.4 times any basket gain, capped at 35%; par if basket falls by up to 30%; if basket falls by more than 30%, 1% loss for each 1% decline
Initial levels:$34.10 for Pfizer, $62.62 for Bristol-Myers Squibb, $64.27 for Merck and $82.92 for Eli Lilly
Contingent buffer:30%
Pricing date:Sept. 8
Settlement date:Sept. 13
Agent:J.P. Morgan Securities LLC
Fees:2%
Cusip:46647M6Q1

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.